Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4484429 | 0.88 | ALDH1A1 (0.38) | LMNASMN1; SMN2RAB9AALDH1A1GAA | |
| SCHEMBL4497244 | 0.87 | ABCC9 (0.32) | SMN1; SMN2RAB9AGAA | |
| SCHEMBL1880294 | 0.86 | LMNA (0.37) | LMNASMN1; SMN2RAB9AALDH1A1GAA | |
| SCHEMBL1880157 | 0.85 | LMNA (0.36) | LMNASMN1; SMN2RAB9AALDH1A1GAA | |
| SCHEMBL1884212 | 0.83 | SMN1; SMN2 (0.36) | LMNASMN1; SMN2RAB9AALDH1A1GAA | |
| SCHEMBL1878729 | 0.83 | LMNA (0.35) | LMNASMN1; SMN2RAB9AALDH1A1GAA | |
| SCHEMBL1878389 | 0.82 | PDE4B (0.39) | LMNASMN1; SMN2RAB9AALDH1A1GAA | |
| SCHEMBL10872717 | 0.82 | LMNA (0.38) | LMNASMN1; SMN2RAB9AALDH1A1GAA | |
| SCHEMBL1882274 | 0.81 | PDE4B (0.42) | LMNASMN1; SMN2RAB9AALDH1A1GAA | |
| SCHEMBL1878669 | 0.81 | PDE5A (0.42) | LMNASMN1; SMN2RAB9AALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7635664-B2 | Herbicidal substituted benzoylpyrazoles | BAYER CROPSCIENCE AG (DE) | 2009-12-22 | — | — | US | disclosed |
| US-20040110640-A1 | Herbicidal substituted benzoylpyrazoles | BAYER CROPSCIENCE AG (DE) | 2004-06-10 | — | — | US | disclosed |
| EP-1395565-A1 | HERBICIDAL SUBSTITUTED BENZOYLPYRAZOLES | Bayer CropScience AG (DE) | 2004-03-10 | — | — | EP | disclosed |
| WO-2002094792-A1 | HERBICIDAL SUBSTITUTED BENZOYLPYRAZOLES | BAYER CROPSCIENCE AG (DE) | 2002-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110640-A1 | Herbicidal substituted benzoylpyrazoles | DDT, GLRX3, CBR3 | LMNA 4604/4885SMN1; SMN2 4258/4885RAB9A 1588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.